Oncolytics Biotech® Announces Preliminary Collaboration with GCAR for Inclusion of Pelareorep in Anticipated Pancreatic Cancer Trial
produce registration-enabling data.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.47 CAD | +2.80% | -1.34% | -17.88% |
1st Jan change | Capi. | |
---|---|---|
-17.88% | 79.28M | |
+52.72% | 55.7B | |
+41.08% | 39.91B | |
-5.30% | 39.57B | |
-5.56% | 28.16B | |
+16.27% | 26.3B | |
-20.92% | 18.94B | |
+33.34% | 12.17B | |
+26.57% | 12.12B | |
+2.24% | 12.12B |